{"groups":[{"description":"Pazopanib 800 mg (tablets) administered orally once a day","id":"FG000","title":"Pazopanib 800 mg"},{"description":"Matching Placebo administered orally once a day","id":"FG001","title":"Placebo"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"5"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"3"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"194"},{"groupId":"FG001","numSubjects":"100"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"290"},{"groupId":"FG001","numSubjects":"145"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"68"},{"groupId":"FG001","numSubjects":"37"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"222"},{"groupId":"FG001","numSubjects":"108"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}